A detailed history of Kent Lake Capital LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Kent Lake Capital LLC holds 328,291 shares of LUNG stock, worth $2.08 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
328,291
Holding current value
$2.08 Million
% of portfolio
0.96%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.77 - $9.82 $1.89 Million - $3.22 Million
328,291 New
328,291 $2.08 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Kent Lake Capital LLC Portfolio

Follow Kent Lake Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kent Lake Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kent Lake Capital LLC with notifications on news.